Concurrent Investment Advisors’s Gilead Sciences GILD Stock Holding History

Concurrent Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Buy	75,185 +3,077	+4%	+$431K	0.11%	196
2025 Q4	$8.85M	Buy	72,108 +16,800	+30%	+$2.04M	0.1%	214
2025 Q3	$6.14M	Buy	55,308 +2,497	+5%	+$284K	0.11%	206
2025 Q2	$5.86M	Buy	52,811 +15,164	+40%	+$1.61M	0.11%	193
2025 Q1	$4.22M	Buy	37,647 +7,928	+27%	+$818K	0.1%	220
2024 Q4	$2.75M	Sell	29,719 -298	-1%	-$26.8K	0.07%	259
2024 Q3	$2.52M	Buy	30,017 +907	+3%	+$69.2K	0.07%	251
2024 Q2	$2M	Buy	29,110 +2,570	+10%	+$172K	0.07%	280
2024 Q1	$1.94M	Sell	26,540 -686	-3%	-$52.8K	0.08%	248
2023 Q4	$2.21M	Buy	+27,226	New	+$2.12M	0.1%	212

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Concurrent Investment Advisors's GILD Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, buying an estimated $431K and bringing the position to 75,185 shares worth $10.5M. The position accounts for 0.11% of the portfolio, ranked #196.

Concurrent Investment Advisors first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Concurrent Investment Advisors held 75,185 shares of Gilead Sciences worth $10.5M as of Q1 2026.
Concurrent Investment Advisors bought 3,077 Gilead Sciences shares in Q1 2026, an estimated $431K.
Gilead Sciences made up 0.11% of Concurrent Investment Advisors's portfolio in Q1 2026, its #196 holding.
Concurrent Investment Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.